Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company's management will present at the19th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland.
https://mma.prnewswire.com/media/1879039/Virax_Biolabs_Logo_Logo.jpg
Presentation Details:
Title: Evaluation of T cell dysfunction in post acute infection syndromesPresenter:Dr. Nigel McCracken, Chief Operating Officer at Virax BiolabsDate:Wednesday, March 12, 2025, at20:00Location:Foyer A1, The Congress Center,Davos, Switzerland
Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and potential customers.
WIRM 2025 is an esteemed conference where approximately 600 scientists and clinicians from around the globe gather to discuss the latest advancements in immunology. This four-day event combines top-tier scientific lectures, informal networking, and a poster exhibition, all set against the stunning backdrop of Davos.
About Virax Biolabs Group Limited
Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.
For more information, please visitwww.viraxbiolabs.com.
Investor Relations Contact:
Russo Partners, LLCNic Johnson12 West 27th Street4th FloorNew York, NY10001M: 303-482-6405nic.johnson@russopartnersllc.com
https://c212.net/c/img/favicon.png?sn=NY33659&sd=2025-03-05
View original content to download multimedia:https://www.prnewswire.com/news-releases/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting-302392440.html
SOURCE Virax Biolabs
https://rt.newswire.ca/rt.gif?NewsItemId=NY33659&Transmission_Id=202503050730PR_NEWS_USPR_____NY33659&DateId=20250305